Jaffetilchin Investment Partners’s Edwards Lifesciences EW Stock Holding History

Jaffetilchin Investment Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21	Closed	-$1.39K	–	655
2024 Q3	$1.39K	Buy	+21	New	+$1.53K	﹤0.01%	1218
2019 Q2	–	Sell	-10,305	Closed	-$657K	–	281
2019 Q1	$657K	Buy	10,305 +462	+5%	+$26.4K	0.15%	117
2018 Q4	$503K	Buy	+9,843	New	+$498K	0.13%	121
2018 Q1	–	Sell	-8,850	Closed	-$332K	–	328
2017 Q4	$332K	Buy	+8,850	New	+$325K	0.11%	172
2016 Q4	–	Sell	-13,344	Closed	-$536K	–	264
2016 Q3	$536K	Buy	13,344 +3,030	+29%	+$114K	0.17%	93
2016 Q2	$343K	Sell	10,314 -6,375	-38%	-$218K	0.1%	162
2016 Q1	$491K	Sell	16,689 -135	-0.8%	-$3.73K	0.16%	81
2015 Q4	$443K	Buy	+16,824	New	+$437K	0.14%	101
2015 Q3	–	Sell	-43,752	Closed	-$1.04M	–	200
2015 Q2	$1.04M	Sell	43,752 -25,560	-37%	-$577K	0.31%	55
2015 Q1	$1.65M	Buy	69,312 +54,744	+376%	+$1.23M	0.5%	30
2014 Q4	$309K	Sell	14,568 -7,110	-33%	-$143K	0.1%	167
2014 Q3	$369K	Buy	+21,678	New	+$342K	0.14%	127

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jaffetilchin Investment Partners's EW Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 21 shares — an estimated $1.39K sold.

Jaffetilchin Investment Partners first reported a position in EW in Q3 2014 and held it in 12 quarters. The position peaked at $1.65M in Q1 2015. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2024.

Jaffetilchin Investment Partners reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
Jaffetilchin Investment Partners sold 21 Edwards Lifesciences shares in Q4 2024, an estimated $1.39K.
Jaffetilchin Investment Partners first reported a position in Edwards Lifesciences in Q3 2014 and held it in 12 quarters.
Jaffetilchin Investment Partners's Edwards Lifesciences position peaked at $1.65M in Q1 2015.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.